• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《视网膜母细胞瘤中的 microRNAs:潜在的诊断和治疗生物标志物》

MicroRNAs in retinoblastoma: Potential diagnostic and therapeutic biomarkers.

机构信息

Department of Ophthalmology, Faculty of Medicine, Isfahan Eye Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.

Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, Iran.

出版信息

J Cell Physiol. 2018 Apr;233(4):3016-3023. doi: 10.1002/jcp.26070. Epub 2017 Aug 30.

DOI:10.1002/jcp.26070
PMID:28657205
Abstract

Retinoblastoma (Rb) is known as one of important childhood malignancies which due to inactivation of the RB gene (tumor suppressor gene in various patients). The early detection of Rb could provide better treatment for Rb patients. Imaging techniques (e.g., MRI and CT) are known as one of effective diagnosis approaches for detection of patients with Rb. It has been shown that utilization of imaging techniques is associated with some limitations. Hence, identification of new diagnosis approaches might provide a better treatment for Rb patients. Identification of new biomarkers could contribute to better understanding of pathogenesis events involved in Rb and provide new insights into design better treatment approaches for these patients. Among the various biomarkers, microRNAs (miRNAs) have emerged as attractive tools for Rb detection. miRNAs are one classes of small non-coding RNAs which could anticipate in a variety of biological process via targeting sequence of cellular and molecular pathways. Deregulations of these molecules are associated with cancerous condition. Multiple lines of evidence indicated that deregulation of various miRNAs involved in various stages of Rb. Here, we summarized a variety of tissue-specific and circulating miRNAs involved in Rb pathogenesis which could be used as diagnostic, prognostic, and therapeutic biomarkers in Rb patients.

摘要

视网膜母细胞瘤(Rb)是一种重要的儿童恶性肿瘤,由于 RB 基因(各种患者的肿瘤抑制基因)失活所致。早期发现 Rb 可以为 Rb 患者提供更好的治疗。成像技术(例如 MRI 和 CT)是检测 Rb 患者的有效诊断方法之一。已经表明,成像技术的应用存在一些局限性。因此,确定新的诊断方法可能为 Rb 患者提供更好的治疗。鉴定新的生物标志物可以帮助更好地了解 Rb 中涉及的发病机制事件,并为这些患者设计更好的治疗方法提供新的见解。在各种生物标志物中,microRNAs(miRNAs)已成为 Rb 检测的有吸引力的工具。miRNAs 是一类小分子非编码 RNA,可以通过靶向细胞和分子途径的序列来参与多种生物学过程。这些分子的失调与癌症状况有关。有多项证据表明,涉及 Rb 各个阶段的多种 miRNAs 的失调。在这里,我们总结了涉及 Rb 发病机制的各种组织特异性和循环 miRNAs,它们可以作为 Rb 患者的诊断、预后和治疗生物标志物。

相似文献

1
MicroRNAs in retinoblastoma: Potential diagnostic and therapeutic biomarkers.《视网膜母细胞瘤中的 microRNAs:潜在的诊断和治疗生物标志物》
J Cell Physiol. 2018 Apr;233(4):3016-3023. doi: 10.1002/jcp.26070. Epub 2017 Aug 30.
2
Serum exosomal miRNA as biomarkers for Retinoblastoma.血清外泌体 miRNA 作为成视网膜细胞瘤的生物标志物。
Exp Eye Res. 2020 Oct;199:108184. doi: 10.1016/j.exer.2020.108184. Epub 2020 Aug 11.
3
Advancements in the diagnosis, prognosis, and treatment of retinoblastoma.视网膜母细胞瘤的诊断、预后和治疗进展。
Can J Ophthalmol. 2024 Oct;59(5):281-299. doi: 10.1016/j.jcjo.2024.01.018. Epub 2024 Feb 15.
4
The functional role of circular RNAs in the pathogenesis of retinoblastoma: a new potential biomarker and therapeutic target?环状 RNA 在视网膜母细胞瘤发病机制中的功能作用:一种新的潜在生物标志物和治疗靶点?
Clin Transl Oncol. 2023 Aug;25(8):2350-2364. doi: 10.1007/s12094-023-03144-2. Epub 2023 Mar 31.
5
MicroRNAs and exosomes in depression: Potential diagnostic biomarkers.抑郁症中的 microRNAs 和外泌体:潜在的诊断生物标志物。
J Cell Biochem. 2018 May;119(5):3783-3797. doi: 10.1002/jcb.26599. Epub 2018 Jan 19.
6
Long non-coding RNAs involved in retinoblastoma.参与视网膜母细胞瘤的长链非编码RNA
J Cancer Res Clin Oncol. 2023 Jan;149(1):401-421. doi: 10.1007/s00432-022-04398-z. Epub 2022 Oct 28.
7
MicroRNA‑758 inhibits malignant progression of retinoblastoma by directly targeting PAX6.MicroRNA-758 通过直接靶向 PAX6 抑制视网膜母细胞瘤的恶性进展。
Oncol Rep. 2018 Sep;40(3):1777-1786. doi: 10.3892/or.2018.6563. Epub 2018 Jul 12.
8
Expression profiles and prognostic value of miRNAs in retinoblastoma.miRNAs 在视网膜母细胞瘤中的表达谱及预后价值。
J Cancer Res Clin Oncol. 2019 Jan;145(1):1-10. doi: 10.1007/s00432-018-2773-7. Epub 2018 Oct 22.
9
Circulating miRNome detection analysis reveals 537 miRNAS in plasma, 625 in extracellular vesicles and a discriminant plasma signature of 19 miRNAs in children with retinoblastoma from which 14 are also detected in corresponding primary tumors.循环微小 RNA 组检测分析显示,在患有视网膜母细胞瘤的儿童的血浆中有 537 种 miRNA,在细胞外囊泡中有 625 种 miRNA,并且有 19 种 miRNA 的血浆特征具有鉴别性,其中 14 种也在相应的原发性肿瘤中被检测到。
PLoS One. 2020 Apr 14;15(4):e0231394. doi: 10.1371/journal.pone.0231394. eCollection 2020.
10
miRNA signature identification of retinoblastoma and the correlations between differentially expressed miRNAs during retinoblastoma progression.视网膜母细胞瘤的miRNA特征鉴定以及视网膜母细胞瘤进展过程中差异表达miRNA之间的相关性。
Mol Vis. 2015 Dec 14;21:1307-17. eCollection 2015.

引用本文的文献

1
Tumor heterogeneity in retinoblastoma: a literature review.视网膜母细胞瘤中的肿瘤异质性:文献综述
Cancer Metastasis Rev. 2025 Apr 22;44(2):46. doi: 10.1007/s10555-025-10263-5.
2
Potential roles of circulating microRNAs in the healing of type 1 diabetic wounds treated with green tea extract: molecular and biochemical study.循环微RNA在绿茶提取物治疗1型糖尿病伤口愈合中的潜在作用:分子与生化研究
Heliyon. 2023 Nov 3;9(11):e22020. doi: 10.1016/j.heliyon.2023.e22020. eCollection 2023 Nov.
3
The key role of microRNA-766 in the cancer development.
微小RNA-766在癌症发展中的关键作用。
Front Oncol. 2023 May 2;13:1173827. doi: 10.3389/fonc.2023.1173827. eCollection 2023.
4
Retinoblastoma: Review and new insights.视网膜母细胞瘤:综述与新见解。
Front Oncol. 2022 Nov 2;12:963780. doi: 10.3389/fonc.2022.963780. eCollection 2022.
5
The long noncoding RNA MALAT1/microRNA-598-3p axis regulates the proliferation and apoptosis of retinoblastoma cells through the PI3K/AKT pathway.长链非编码 RNA MALAT1/miRNA-598-3p 轴通过 PI3K/AKT 通路调节视网膜母细胞瘤细胞的增殖和凋亡。
Mol Vis. 2022 Sep 4;28:269-279. eCollection 2022.
6
Review: New horizons in retinoblastoma treatment: an updated review article.综述:视网膜母细胞瘤治疗的新视野:一篇更新的综述文章。
Mol Vis. 2022 Jul 11;28:130-146. eCollection 2022.
7
Recent achievements in nano-based technologies for ocular disease diagnosis and treatment, review and update.基于纳米技术的眼部疾病诊断和治疗的最新进展,综述与更新。
J Nanobiotechnology. 2022 Aug 2;20(1):361. doi: 10.1186/s12951-022-01567-7.
8
A Pan-Cancer Analysis of the Oncogenic Role of : A Potential Biomarker for Prognosis and Immunotherapy.:一种潜在的预后和免疫治疗生物标志物的致癌作用的泛癌分析。 (注:原文冒号前内容不完整)
Front Genet. 2022 Jul 15;13:906174. doi: 10.3389/fgene.2022.906174. eCollection 2022.
9
Krüppel-like transcription factor 16 transcriptional up-regulation of cellular retinoic acid-binding proteins-2 promotes the invasion and migration and inhibits apoptosis of retinoblastoma cells by regulating integrin-β1/focal adhesion kinase /extracellular signal-regulated kinase pathway.Krüppel 样转录因子 16 转录上调细胞视黄酸结合蛋白 2 促进视网膜母细胞瘤细胞的侵袭和迁移,通过调节整合素-β1/黏着斑激酶/细胞外信号调节激酶通路抑制细胞凋亡。
Bioengineered. 2022 Feb;13(2):3694-3706. doi: 10.1080/21655979.2021.2024977.
10
Applications of Non-Coding RNAs in Patients With Retinoblastoma.非编码RNA在视网膜母细胞瘤患者中的应用
Front Genet. 2022 Mar 31;13:842509. doi: 10.3389/fgene.2022.842509. eCollection 2022.